Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01DCJ
|
|||
| Former ID |
DIB000884
|
|||
| Drug Name |
GRNOPC-1
|
|||
| Synonyms |
Human embryonic stem cell therapy (Parkinson's disease/stroke/Alzheimers disease/multiple sclerosis/spinal cord injury/canavan disease), Geron
Click to Show/Hide
|
|||
| Indication | Spinal cord injury [ICD-11: ND51.2] | Phase 1 | [1], [2] | |
| Company |
Geron Corp
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Geron Corp. | |||
| REF 2 | ClinicalTrials.gov (NCT01217008) Safety Study of GRNOPC1 in Spinal Cord Injury. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.